Variables | All (n = 221) | Female (n = 125) | Male (n = 96) | Pa |
---|---|---|---|---|
Overall cumulative mortality | ||||
 All-cause | 64 (56.5) | 35 (44.3) | 29 (63.7) | 0.704 |
 Cardiovascular | 22 (28.1) | 14 (25.2) | 8 (28.3) | 0.561 |
One-year cumulative mortality | ||||
 All-cause | 32 (15.5) | 20 (17.2) | 12 (13.3) | 0.601 |
 Cardiovascular | 12 (6.1) | 7 (6.4) | 5 (5.7) | 0.762 |
30-day cumulative mortality | ||||
 All-cause | 10 (4.1) | 5 (4.0) | 5 (5.2) | 0.939 |
 Cardiovascular | 6 (2.7) | 3 (2.4) | 3 (3.1) | 0.781 |
30-day VARC-2 defined outcomes | ||||
 Stroke or transient ischemic attack | 4 (2.0) | 2 (1.7) | 2 (2.3) | 0.997 |
 Life threatening bleeding | 7 (3.4) | 2 (1.7) | 5 (5.6) | 0.212 |
 Acute kidney injury, stage 2 or 3 | 15 (7.1) | 6 (5.0) | 9 (9.9) | 0.751 |
 Coronary artery obstruction | 2 (1.0) | 1 (0.9) | 1 (1.1) | 0.805 |
 Myocardial infarction | 4 (2.0) | 2 (1.7) | 2 (2.3) | 0.387 |
 Major vascular complications | 5 (2.4) | 0 (0) | 5 (5.6) | 0.953 |
 New pacemaker implantation | 8 (3.9) | 3 (2.5) | 5 (5.6) | 0.142 |
 Moderate to severe paravalvular leakage | 5 (2.4) | 3 (2.5) | 2 (2.3) | 0.825 |
 Valve-related dysfunction requiring repeat procedureb | 1 (0.5) | 1 (0.9) | 0 (0) | 0.978 |